Cancer Cells with Defective RB and CDKN2A Are Resistant to the Apoptotic Effects of Rapamycin

0
10
Scientists observed that DU145 prostate and NCI–H2228 lung cancer cells were resistant to the cytotoxic effect of rapamycin.
[Cancer Letters]
Abstract